Therapeutic Potential of Resveratrol in Lymphoid Malignancies

References

• Belchi-Navarro S, Almagro L, Sabater-Jara AB, Fernandez-Perez F, Bru R, et al.: Induction of trans-resveratrol and extracellular pathogenesis-related proteins in elicited suspension cultured cells of Vitis vinifera cv Monastrell. J Plant Physiol 170, 258–264, 2013.
   PubMed Web of Science ®Google Scholar
• Soleas GJ, Diamandis EP, and Goldberg DM: The world of resveratrol. Adv Exp Med Biol 492, 159–182, 2001.
   PubMed Web of Science ®Google Scholar
• Timmers S, Auwerx J, and Schrauwen P: The journey of resveratrol from yeast to human. Aging (Albany NY) 4,146–158, 2012.
   PubMedGoogle Scholar
• Agarwal B and Baur JA: Resveratrol and life extension. Ann N Y Acad Sci 1215, 138–143, 2011.
   PubMed Web of Science ®Google Scholar
• Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, et al.: Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686–689, 2004.
   PubMed Web of Science ®Google Scholar
• Athar M, Back JH, Tang X, Kim KH, Kopelovich L, et al.: Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224, 274–283, 2007.
   PubMed Web of Science ®Google Scholar
• Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, and Goldberg DM: Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 246, 163–182, 1996.
   PubMed Web of Science ®Google Scholar
• Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A, et al.: Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 61: 2103–2110, 1997.
   PubMed Web of Science ®Google Scholar
• Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, et al.: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218–220, 1997.
   PubMed Web of Science ®Google Scholar
• Aziz MH, Kumar R, and Ahmad N: Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol 23, 17–28, 2003.
   PubMed Web of Science ®Google Scholar
• Baur JA and Sinclair DA: Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5, 493–506, 2006.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Im JH, Won SY, Kim YB, Cho MK, et al.: Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells. Food Chem Toxicol 52, 61–68, 2013.
   PubMed Web of Science ®Google Scholar
• Castillo-Pichardo L and Dharmawardhane SF: Grape polyphenols inhibit Akt/mammalian target of rapamycin signaling and potentiate the effects of gefitinib in breast cancer. Nutr Cancer 64, 1058–1069, 2012.
   PubMed Web of Science ®Google Scholar
• Can G, Cakir Z, Kartal M, Gunduz U, and Baran Y: Apoptotic effects of resveratrol, a grape polyphenol, on imatinib-sensitive and resistant K562 chronic myeloid leukemia cells. Anticancer Res 32, 2673–2678, 2012.
   PubMed Web of Science ®Google Scholar
• Iguchi K, Toyama T, Ito T, Shakui T, Usui S, et al.: Antiandrogenic activity of resveratrol analogs in prostate cancer LNCaP cells. J Androl 33, 1208–1215, 2012.
   PubMed Web of Science ®Google Scholar
• Juan ME, Alfaras I, and Planas JM: Colorectal cancer chemoprevention by trans-resveratrol. Pharmacol Res 65, 584–591, 2012.
   PubMed Web of Science ®Google Scholar
• Hussain AR, Uddin S, Bu R, Khan OS, Ahmed SO, et al.: Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines. PLoS ONE 6: e24703, 2011.
   PubMed Web of Science ®Google Scholar
• Delmas D, Solary E, and Latruffe N: Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. Curr Med Chem 18, 1100–1121, 2011.
   PubMed Web of Science ®Google Scholar
• Wallace DC: Mitochondrial diseases in man and mouse. Science 283, 1482–1488, 1999.
   PubMed Web of Science ®Google Scholar
• Mignotte B and Vayssiere JL: Mitochondria and apoptosis. Eur J Biochem 252, 1–15, 1998.
   PubMedGoogle Scholar
• Sengottuvelan M, Deeptha K, and Nalini N: Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis. Chem Biol Interact 181, 193–201, 2009.
   PubMed Web of Science ®Google Scholar
• Jiang H, Shang X, Wu H, Gautam SC, Al-Holou S, et al.: Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells. J Exp Ther Oncol 8, 25–33, 2009.
   PubMedGoogle Scholar
• Holme AL and Pervaiz S: Resveratrol in cell fate decisions. J Bioenerg Biomembr 39, 59–63, 2007.
   PubMed Web of Science ®Google Scholar
• Fulda S and Debatin KM: Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review. Cancer Detect Prev 30, 217–223, 2006.
   PubMedGoogle Scholar
• Shimizu T, Nakazato T, Xian MJ, Sagawa M, Ikeda Y, et al.: Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways. Biochem Pharmacol 71, 742–750, 2006.
   PubMed Web of Science ®Google Scholar
• Faber AC, Dufort FJ, Blair D, Wagner D, Roberts MF, et al.: Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas. Biochem Pharmacol 72, 1246–1256, 2006.
   PubMed Web of Science ®Google Scholar
• Guha P, Dey A, Sen R, Chatterjee M, Chattopadhyay S, et al.: Intracellular GSH depletion triggered mitochondrial Bax translocation to accomplish resveratrol-induced apoptosis in the U937 cell line. J Pharmacol Exp Ther 336, 206–214, 2011.
   PubMed Web of Science ®Google Scholar
• Quoc Trung L, Espinoza JL, Takami A, and Nakao S: Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition. PLoS ONE 8: e55183, 2013.
   PubMed Web of Science ®Google Scholar
• De Leo A, Arena G, Lacanna E, Oliviero G, Colavita F, et al.: Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets. Antiviral Res 96, 196–202, 2012.
   PubMed Web of Science ®Google Scholar
• Dorrie J, Gerauer H, Wachter Y, Zunino SJ: Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res 61, 4731–4739, 2001.
   PubMed Web of Science ®Google Scholar
• Falini B: Anaplastic large cell lymphoma: pathological, molecular and clinical features. Br J Haematol 114, 741–760, 2001.
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, et al.: Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A 79, 7824–7827, 1982.
   PubMed Web of Science ®Google Scholar
• Ko YC, Chang CL, Chien HF, Wu CH, Lin LI: Resveratrol enhances the expression of death receptor Fas/CD95 and induces differentiation and apoptosis in anaplastic large-cell lymphoma cells. Cancer Lett 309, 46–53, 2011.
   PubMed Web of Science ®Google Scholar
• Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S: Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92, 996–1002, 1998.
   PubMed Web of Science ®Google Scholar
• Krammer PH: CD95's deadly mission in the immune system. Nature 407, 789–795, 2000.
   PubMed Web of Science ®Google Scholar
• Escalon MP and Lossos IS: Pharmacotherapy of large B-cell lymphoma. Expert Opin Pharmacother 9: 2247–2258, 2008.
   PubMed Web of Science ®Google Scholar
• Fisher RI: Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphoma. Cancer Chemother Pharmacol 40 (Suppl), S42–46, 1997.
   PubMed Web of Science ®Google Scholar
• Staudt LM and Dave S: The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol 87, 163–208, 2005.
   PubMed Web of Science ®Google Scholar
• Markovic O, Marisavljevic D, Cemerikic V, Perunicic M, Savic S, et al.: Clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large B-cell lymphoma (DLBCL). Eur J Haematol 86, 246–255, 2011.
   PubMed Web of Science ®Google Scholar
• Uddin S, Hussain AR, Siraj AK, Manogaran PS, Al-Jomah NA, et al.: Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood 108, 4178–4186, 2006.
   PubMed Web of Science ®Google Scholar
• Juan ME, Wenzel U, Daniel H, Planas JM: Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells. J Agric Food Chem 56, 4813–4818, 2008.
   PubMed Web of Science ®Google Scholar
• Cuevas B, Lu Y, Watt S, Kumar R, Zhang J, et al.: SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity. J Biol Chem 274, 27583—27589, 1999.
   PubMed Web of Science ®Google Scholar
• Hussain AR, Al-Rasheed M, Manogaran PS, Al-Hussein KA, Platanias LC, et al.: Curcumin induces apoptosis via inhibition of PI3′-kinase/AKT pathway in acute T cell leukemias. Apoptosis 11, 245–254, 2006.
   PubMed Web of Science ®Google Scholar
• Nunez L, Villalobos C, and Frawley LS: Extracellular ATP as an autocrine/paracrine regulator of prolactin release. Am J Physiol 272, E1117–1123, 1997.
   PubMed Web of Science ®Google Scholar
• Kwon D, Choi K, Choi C, and Benveniste EN: Hydrogen peroxide enhances TRAIL-induced cell death through up-regulation of DR5 in human astrocytic cells. Biochem Biophys Res Commun 372, 870–874, 2008.
   PubMed Web of Science ®Google Scholar
• Lee TJ, Um HJ, Min do S, Park JW, Choi KS, et al.: Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic Biol Med 46, 1639–1649, 2009.
   PubMed Web of Science ®Google Scholar
• Pervaiz S and Holme AL: Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 11, 2851–2897, 2009.
   PubMed Web of Science ®Google Scholar
• Prasad S, Yadav VR, Kannappan R, and Aggarwal BB: Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-Independent upregulation of death receptors: Evidence for the role of reactive oxygen species and C-Jun N-terminal kinase. J Biol Chem. 286, 5546-5557, 2011.
   Web of Science ®Google Scholar
• Prasad S, Yadav VR, Ravindran J, and Aggarwal BB: ROS and CHOP Are Critical for Dibenzylideneacetone to Sensitize Tumor Cells to TRAIL through Induction of Death Receptors and Downregulation of Cell Survival Proteins. Cancer Res 71, 538–549, 2011.
   PubMed Web of Science ®Google Scholar
• Bruno B, Giaccone L, Rotta M, Anderson K, and Boccadoro M: Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside. Leukemia 19, 1729–1738, 2005.
   PubMed Web of Science ®Google Scholar
• Hideshima T, Chauhan D, Richardson P, and Anderson KC: Identification and validation of novel therapeutic targets for multiple myeloma. J Clin Oncol 23, 6345–6350, 2005.
   PubMed Web of Science ®Google Scholar
• Jazirehi AR and Bonavida B: Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther 3, 71–84, 2004.
   PubMed Web of Science ®Google Scholar
• Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T, et al.: Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res 65, 9943–9952, 2005.
   PubMed Web of Science ®Google Scholar
• Bhardwaj A, Sethi G, Vadhan-Raj S, Bueso-Ramos C, Takada Y, et al.: Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109, 2293–2302, 2007.
   PubMed Web of Science ®Google Scholar
• Kupisiewicz K: Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention. Dan Med Bull 58, B4277, 2011.
   PubMed Web of Science ®Google Scholar
• Sun CY, Hu Y, Guo T, Wang HF, Zhang XP, et al.: Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity. Acta Pharmacol Sin 27: 1447–1452, 2006.
   PubMed Web of Science ®Google Scholar
• Wang FM, Galson DL, Roodman GD, and Ouyang H: Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses pro-survival XBP1 signaling in human multiple myeloma cells. Exp Hematol 39, 999–1006, 2011.
   PubMed Web of Science ®Google Scholar
• Hallek M, Bergsagel PL, and Anderson KC: Multiple myeloma: increasing evidence for a multistep transformation process. Blood 91, 3–21, 1998.
   PubMed Web of Science ®Google Scholar
• Feinman R, Koury J, Thames M, Barlogie B, Epstein J, et al.: Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood 93, 3044–3052, 1999.
   PubMed Web of Science ®Google Scholar
• Ma MH, Yang HH, Parker K, Manyak S, Friedman JM, et al.: The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents. Clin Cancer Res 9, 1136–1144, 2003.
   PubMed Web of Science ®Google Scholar
• Chauhan D and Anderson KC: Mechanisms of cell death and survival in multiple myeloma (MM): Therapeutic implications. Apoptosis 8, 337–343, 2003.
   PubMed Web of Science ®Google Scholar
• Luo JL, Kamata H, and Karin M: IKK/NF-kappaB signaling: balancing life and death–a new approach to cancer therapy. J Clin Invest 115, 2625–2632, 2005.
   PubMed Web of Science ®Google Scholar
• Tran NL, McDonough WS, Savitch BA, Sawyer TF, Winkles JA, et al.: The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression. J Biol Chem 280, 3483–3492, 2005.
   PubMed Web of Science ®Google Scholar
• Yang W, Cooke M, Duckett CS, Yang X, Dorsey JF: Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells. Cell Cycle 13, 992–1005, 2014.
   PubMed Web of Science ®Google Scholar
• Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, et al.: Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12, 131–144, 2007.
   PubMed Web of Science ®Google Scholar
• Oancea M, Mani A, Hussein MA, and Almasan A: Apoptosis of multiple myeloma. Int J Hematol 80, 224–231, 2004.
   PubMed Web of Science ®Google Scholar
• Estrov Z, Shishodia S, Faderl S, Harris D, Van Q, et al.: Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 102, 987–995, 2003.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Darjatmoko SR, Polans AS: Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB. Melanoma Res 21, 180–187, 2011.
   PubMed Web of Science ®Google Scholar
• Aquino G, Marra L, Cantile M, De Chiara A, Liguori G, et al.: MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas. Infect Agent Cancer 8, 37, 2013.
   PubMed Web of Science ®Google Scholar
• De Leo A, Arena G, Stecca C, Raciti M, and Mattia E: Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program. Mol Cancer Res 9, 1346–1355, 2011.
   PubMed Web of Science ®Google Scholar
• Non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89, 3909–3918, 1997.
   PubMed Web of Science ®Google Scholar
• Cecconi D, Zamo A, Parisi A, Bianchi E, Parolini C, et al.: Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol: a proteomic analysis. J Proteome Res 7, 2670–2680, 2008.
   PubMed Web of Science ®Google Scholar
• Cleary ML, Smith SD, and Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47, 19–28, 1986.
   PubMed Web of Science ®Google Scholar
• Hockenbery DM, Zutter M, Hickey W, Nahm M, and Korsmeyer SJ: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 88, 6961–6965, 1991.
   PubMed Web of Science ®Google Scholar
• Gandhi MK and Marcus RE: Follicular lymphoma: time for a re-think? Blood Rev 19, 165–178, 2005.
   PubMed Web of Science ®Google Scholar
• Hiddemann W, Buske C, Dreyling M, Weigert O, Lenz G, et al.: Treatment strategies in follicular lymphomas: current status and future perspectives. J Clin Oncol 23, 6394–6399, 2005.
   PubMed Web of Science ®Google Scholar
• Faber AC and Chiles TC: Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: evidence for a novel mechanism involving inhibition of BCL6 signaling. Int J Oncol 29, 1561–1566, 2006.
   PubMed Web of Science ®Google Scholar
• Caprio M, Fabbrini E, Isidori AM, Aversa A and Fabbri A: Leptin in reproduction. Trends Endocrinol Metab 12, 65–72, 2001.
   PubMed Web of Science ®Google Scholar
• Kanzler H, Kuppers R, Hansmann ML and Rajewsky K: Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 184, 1495–1505, 1996.
   PubMed Web of Science ®Google Scholar
• Marafioti T, Hummel M, Foss HD, Laumen H, Korbjuhn P, et al.: Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 95, 1443–1450, 2000.
   PubMed Web of Science ®Google Scholar
• Frazzi R, Valli R, Tamagnini I, Casali B, Latruffe N, et al.: Resveratrol-mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation. Int J Cancer 132, 1013–1021, 2013.
   PubMed Web of Science ®Google Scholar